Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 729-732, October 2007

Barriers to achieving commercial success for diagnostic and therapeutic radiopharmaceuticals☆

Oncology Medical Research, Biogen Idec, San Diego, CA 92130, USA

Received 26 March 2007; accepted 8 April 2007. published online 11 June 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ After bench to bedside: impact on clinical outcome (February 25, 2007).

PII: S0969-8051(07)00100-X

doi:10.1016/j.nucmedbio.2007.04.004

Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 729-732, October 2007

Article Tools

* Image Usage & Resolution